Grant✓ Small businesses may apply

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

National Institutes of Health

Award ceiling

$150,000

Program funding

$150,000

Opportunity #: PAR-25-101
Agency: National Institutes of Health
ALN (CFDA): 93.279
Status: posted
Posted: Dec 30, 2024
Closes: Aug 11, 2027
Funding instrument: Grant
Category: Education, Health
Cost sharing required: No

Who can apply

•Public housing authorities/Indian housing authorities
•Native American tribal organizations (other than Federally recognized tribal governments)
•Independent school districts
•Native American tribal governments (Federally recognized)
•City or township governments
•For profit organizations other than small businesses
•Others (see text field entitled "Additional Information on Eligibility" for clarification)
•County governments
•Public and State controlled institutions of higher education
•Special district governments
•Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
•Small businesses
•State governments
•Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
•Private institutions of higher education

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Synopsis

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

Contact

National Institutes of Health · grantsinfo@nih.gov

View full notice on Grants.gov ↗